World ADC Berlin 2018

Now in it's 8th year, World ADC Berlin is Europe's leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.

Attend World ADC Berlin next year to validate novel ADC targets, improve understanding of mechanisms driving toxicity in clinical development and robustly scale up process development to support commercialisation. For 2018, 320 drug developers across 140+ active organisations will unite at this industry focussed conference to foster new connections, further develop business relationships and meet with current partners.

Join your peers at Europe's longest standing and most comprehensive ADC conference to power the development of your ADC pipeline.

URLs:
Brochure: https://go.evvnt.com/172307-1?pid=1358
Booking: https://go.evvnt.com/172307-2?pid=1358

Prices:
Earlybird Conference Price: EUR 2199
Standard Conference Price: EUR 2499

Speakers: Alain Beck Pierre-Fabre, Alex Lazar ImmunoGen, Alexander Chu-Kung AbbVie, Aman Singh Johnson and Johnson, Anette Sommer Bayer, Anthony Tolcher START, Arnaud Delobel Quality Assistance, Carli Uli Bialucha Novartis, Charles Dumontet Cancer Research Centre Lyon, Christoffer Nielsen The Finsen Laboratory, Conor Barry MedImmune/Spirogen, Daisuke Okajima Daiichi Sankyo, David Bramhill Bramhill Biological Consulting, Dawei Xuan Pfizer, Dorota Roberts, Francesca Zammarchi ADC Therapeutics, Francois D'Hooge Novasep, Giorgio Salciarini BSP Pharmaceuticals, Iontcho Vlahov Endocyte, James (Maorong) Ruan MabPlex, Jon Roffey Cancer Research UK, Julia Gavrilyuk AbbVie-Stemcentrx, Julian Andreev Regeneron Pharmaceuticals, Justin Mason-Home HPAPI Project Services Limited, Jutta Wanner BlinkBio, Kurt Gish AbbVie, Laurent Ducry Lonza, Marc Damelin Mersana Therapeutics, Markus Eser Bayer, Mary Jane Hinrichs MedImmune, Maria Marza Perez Synthon, Nicolas Joubert CNRS, Nina Caculitan Genentech, Peter Bach BioPharmaLogic Consulting, Phil Howard Spirogen, Rakesh Dixit MedImmune, Richard Shannon MedImmune, Samuele Cazzamalli ETH Zurich, Scott Dylla AbbVie-Stemcentrx, Silke Weber Roche, Stefan Koenig Genentech, Tami Wu Seattle Genetics, Thomas Schirrmann University of Braunschweig, Ulf Gra

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Development

Date and Time: Monday March 26, 2018 at 8:00 am ends Wednesday March 28, 2018 at 6:00 pm